经皮电神经刺激对非特异性慢性下背痛患者疼痛、功能及下行抑制的影响:一项随机交叉试验的研究方案
本研究为随机交叉试验,计划招募34名非特异性慢性下背痛患者,分别接受活性经皮电神经刺激(TENS)、安慰剂TENS和无治疗对照三种处理。活性TENS采用2-125 Hz调制频率、可变脉宽和最大可耐受强度,持续30分钟,治疗后继续开启以评估最大效应期,总时长50至60分钟。主要结局为静息和运动时的疼痛强度,次要结局包括压痛阈、热痛阈、时间总和、条件性疼痛调制及功能测试。
要点
- 计划样本34例,随机交叉接受活性TENS、安慰剂TENS和无治疗对照三种处理。
- 活性TENS参数:2-125 Hz调制频率、可变脉宽、最大可耐受强度,持续30分钟,总评估时长50至60分钟。
- 主要结局为静息和运动时疼痛强度(数字疼痛评分量表),治疗前后即刻评估。
核心结论
- 本研究将为TENS在非特异性慢性下背痛患者中的效应及机制提供证据,结局包括疼痛、功能和下行抑制,有助于理解TENS如何用于此类患者。
研究设计与样本
- 随机交叉试验,计划招募34名非特异性慢性下背痛患者,从包括哈特福德大学、物理治疗诊所、哈特福德地区当地企业及临床试验招募网站等多处招募。
- 受试者将接受全部三种处理:活性TENS、安慰剂TENS和无治疗对照,处理顺序通过基于网站的随机化工具随机确定。
- 活性TENS采用2-125 Hz调制频率、可变脉宽和最大可耐受强度,持续30分钟;治疗后继续开启TENS以评估最大效应期,总时长50至60分钟;若出现肌肉抽搐可调低强度以确保评估者盲法。
- 安慰剂TENS在45秒内输出电流,最后15秒逐渐降至0。
- 主要结局为静息和运动时疼痛强度,采用数字疼痛评分量表;次要结局包括压痛阈、热痛阈、疼痛时间总和、条件性疼痛调制、坐立试验和重复躯干屈曲;评估在治疗前和治疗后即刻进行。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Low back pain (LBP) is a significant public health problem, is very prevalent, and is often characterized by the persistence of symptoms. Transcutaneous electrical nerve stimulation (TENS) may benefit people with chronic LBP because it can activate descending inhibitory pathways and inhibit central excitability. However, previous studies that have investigated the effects of TENS on pain in people with LBP have failed to use proper intensities of current, and the timing of the assessment of pain was not performed during the peak of the analgesic response or functional activities. Therefore, the present study aims to assess the effects of TENS on measures of pain, function, and descending inhibition using the maximal tolerable intensity of TENS in participants with LBP. METHODS/DESIGN: This study will be a randomized crossover trial. The participants for this study will be recruited from various places, including the University of Hartford, physical therapy clinics, and local businesses in the Hartford area, as well as online websites geared towards clinical trial recruitment. A total of 34 participants will receive all three treatments: active TENS, placebo TENS, and no treatment control. The treatment order will be randomized using a website-based randomization tool. For active TENS, a modulating frequency of 2-125 Hz will be applied with a variable pulse duration and maximal tolerable intensity for 30 min. The TENS will be left on for post-treatment testing to assess the effects during its maximally effective period for a total of 50 to 60 min. Furthermore, the intensity may be turned down if muscle twitching is present to ensure blinding of the evaluator. For placebo TENS, the unit will deliver current for 45 s, ramping to 0 in the last 15 s. The primary outcome will be pain intensity at rest and with movement, determined using the numerical pain rating scale. The secondary outcomes will be pressure pain threshold, heat pain threshold, temporal summation of pain, conditioned pain modulation, sit-to-stand test, and repeated trunk flexion. The assessments will be performed immediately before and after treatment. Statistical analysis of the data obtained will consider a significance level of p < 0.05. DISCUSSION: This study will provide evidence concerning the effects and mechanisms of TENS treatment in participants with chronic non-specific low back pain. The outcomes, including pain, function, and descending inhibition, will help us gain a greater understanding of how TENS can be used for these participants. TRIAL REGISTRATION: ClinicalTrials.gov NCT05812885. Registered on 24th May 2023.
引用
- Liebano RE, Sluka KA, Roy J, et al. Effects of transcutaneous electrical nerve stimulation on pain, function, and descending inhibition in people with non-specific chronic low-back pain: a study protocol for a randomized crossover trial. Trials. 2024. PMID: 38582874. doi:10.1186/s13063-024-08089-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。